Sandoz has announced that Tyruko, the first and only FDA-approved biosimilar for multiple sclerosis (MS), is now available in ...
Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.
SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and ...
Over the past six decades, anti-thrombotic drug therapies have undergone a revolution, leading to major improvements in ...
Markets and regulators will keep shifting, but an agile medical affairs function, built on flexible resourcing and ...
Can you believe there are still outdated myths about the strategic value Medical Affairs (MA) brings to the table? There’s ...
Johnson & Johnson (J&J) has announced new data showing that Tremfya (guselkumab) reduces symptoms of psoriatic arthritis (PsA ...
Systematic literature reviews (SLRs) are a resource heavy, time-consuming but necessary part of evidence generation. SLRs present an opportunity for artificial intelligence (AI) to deliver significant ...
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that ...
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led ...
Novartis has announced plans to build a new flagship US manufacturing hub in North Carolina. The announcement comes as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results